Actionable insights straight to your inbox

Equities logo

CTI BioPharma (CTIC): Updates on Non-Hodgkin Lymphoma and Myelofibrosis

CTI BioPharma provided updates this week on patient enrollments for its non-Hodgkin lymphoma and myelosis clinical trials.
Shares in biotech small-cap Geron Corporation (GERN) gapped up over 100 percent to start Thursday after news that their treatment for the bone marrow disorder myelofibrosis, imelstat, showed